<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               1	INDICATIONS AND USAGE<BR>               <BR>                  ZELBORAF™ is indicated for the treatment of patients with unresectable or metastatic melanoma with BRAFV600E mutation as detected by an FDA-approved test.<BR>                  Limitation of Use: ZELBORAF is not recommended for use in patients with wild-type BRAF melanoma.<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        ZELBORAF™ is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with BRAFV600E mutation as detected by an FDA-approved test. (1, 5.10)  <BR>                        Limitation of Use:  ZELBORAF is not recommended for use in patients with wild-type BRAF melanoma. (5.10, 14)<BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>